The Safety and Effectiveness of Steep Pulse Therapy System for the Ablation of Benign Prostatic Hyperplasia

The goal of this clinical trial is to assess the efficacy of steep pulse ablation in treating benign prostatic hyperplasia (BPH) and to evaluate its safety profile in treating BPH. The main questions it aims to answer are: 1. whether steep pulse ablation can effectively manage BPH symptoms and to investigate any potential safety concerns associated with its use in treating BPH. 2. If steep pulse ablation can perform superior effect than Tamsulosin Hydrochloride in treating BPH. Participants will be asked to do: 1. Participants will be given Tamsulosin Hydrochloride or undergo steep pulse ablation. 2. Participants will be followed up after 1 month and 3 month after taking drug or undergo ablation for test and relative examinations.

NCT Number	NCT06867315
Lead Sponsor	First Affiliated Hospital of Zhejiang University Collaborators: Shanghai Jiao Tong University Affiliated Sixth People's Hospital, The First Affiliated Hospital of University of Science and Technology of China, First People's Hospital of Hangzhou, Fujian Provincial Hospital
Conditions	Benign Prostatic Hyperplasia
Enrollment	10 participants
Start Date	2024-05-29
Primary Completion	2026-05-29 (estimated)
Study Completion	2026-05-29 (estimated)
Updated on ClinicalTrials.gov	2025-03-10